XIDMI
Live / Applied — Suspended — suspension letter mailed (as of 15 Jan 2026)
What this means for you
Not registered yet, but its 16 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99446216
- Mark type
- Stylized text
- Filed
- 16 Oct 2025
- Attorney of record
- Alexandra Kochian
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of autoimmune, immune-mediated, immune-system related, inflammatory, and neurological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of rare autoimmune, rare immune-mediated, rare immune-system related, rare inflammatory, and rare neurological diseases and disorders
Owner
- Sanofi, Paris, FR
Prosecution history
- 15 Jan 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 15 Jan 2026 — LETTER OF SUSPENSION E-MAILED
- 15 Jan 2026 — SUSPENSION LETTER WRITTEN
- 13 Jan 2026 — ASSIGNED TO EXAMINER
- 16 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 16 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 16 Oct 2025 — NEW APPLICATION ENTERED